Results 131 to 140 of about 23,635 (197)

Prognostic value of soluble urokinase-type plasminogen activator receptor in coronary artery disease: A meta-analysis. [PDF]

Eur J Clin Invest, 2022
Li Y, Ding Y, Zhao Y, Gui Y, Shen Y, Xiang Q.   +5 more
europepmc   +1 more source

Role of soluble urokinase type plasminogen activator receptor (suPAR) in predicting mortality, readmission, length of stay and discharge in emergency patients: A systematic review and meta analysis. [PDF]

Medicine (Baltimore), 2023
Rehan ST, Hussain HU, Ali E, Kumar KA, Tabassum S, Hasanain M, Shaikh A, Ali G, Yousaf Z, Asghar MS.   +9 more
europepmc   +1 more source

The relationship between the urokinase-type plasminogen activator gene Pro141Leu polymorphism and patients with prostate cancer. [PDF]

Rev Assoc Med Bras (1992)
Gülüm C, Eroğlu P, Tanrıverdi R, Bozlu M.   +3 more
europepmc   +1 more source

The Urokinase-Type Plasminogen Activator Receptor (uPAR) as a Mediator of Physiological and Pathological Processes: Potential Therapeutic Strategies. [PDF]

Cancers (Basel)
Iftikhar A, Mahmood N, Rabbani SA.
europepmc   +1 more source

Association between Serum Soluble Urokinase-Type Plasminogen Activator Receptor Level and Arterial Stiffness in Chronic Hemodialysis Patients. [PDF]

J Pers Med, 2023
Lin WC, Wu TJ, Wang CH, Hsieh YJ, Hsu BG.   +4 more
europepmc   +1 more source

Predictive Value of Preoperative Neutrophil-to-Lymphocyte Ratio (NLR) and Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) for Biochemical Recurrence After Radical Prostatectomy. [PDF]

Med Sci Monit
Wang H, Huang C.
europepmc   +1 more source

Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer. [PDF]

J Transl Med, 2022
Zhai BT, Tian H, Sun J, Zou JB, Zhang XF, Cheng JX, Shi YJ, Fan Y, Guo DY.   +8 more
europepmc   +1 more source

Virus-derived serpin reduces immuno-coagulopathic damage in murine colitis by targeting the urokinase-type plasminogen activator receptor (uPAR) and complement. [PDF]

Sci Rep
Lucas AR, Monder H, Enow J, Woodrow C, Spaccarelli L, Garg A, Schlievert J, Elmadbouly N, Dupati A, Aliskevich E, Saju R, Kilbourne J, Lowe K, Hamada M, Pinteric A, Zanetti IR, Satyanarayanan RS, Gisriel S, Florsheim EB, Rahman M, Irving J, McFadden G, Kong W, Zhang L.   +23 more
europepmc   +1 more source

Urokinase-Type Plasminogen Activator Receptor (uPAR) Cooperates with Mutated KRAS in Regulating Cellular Plasticity and Gemcitabine Response in Pancreatic Adenocarcinomas. [PDF]

Cancers (Basel), 2023
Peng L, Li Y, Yao S, Gaedcke J, Baart VM, Sier CFM, Neesse A, Ellenrieder V, Bohnenberger H, Fuchs F, Kitz J, Ströbel P, Küffer S.   +12 more
europepmc   +1 more source

Executive function and soluble urokinase-type plasminogen activator receptor (suPAR): a longitudinal study of midlife adults. [PDF]

Brain Behav Immun
Shell A, Vize C, Gianaros P, Rasmussen LJH, Marsland AL.   +4 more
europepmc   +1 more source